Close

p21 protein

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-cyclin-dependent kinase2 or -cyclin-dependent kinase4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen, a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of cyclin-dependent kinase2, and may be instrumental in the execution of apoptosis following caspase activation. Mice that lack this gene have the ability to regenerate damaged or missing tissue. Multiple alternatively spliced variants have been found for this gene.

Associated Disease
    • TCR Vector Products

    • TCR Viral Particles

    Loading...
    • Target Species:
    • Host Species:
    • Epitope:
    • Allele:
    • Vector Type:
    CAT Product Name Target Species TCR Clone Host Species Epitope Allele Vector Type Inquiry & Datasheet
    TCR-L074 Human anti-CDKN1A (LDILDTAGL) T Cell Receptor, pLXSN Human Human LDILDTAGL HLA-A2.1 retroviral vector   Add to Cart   Datasheet
    TCR-L073Z Human anti-p21 protein (aa53-61) T cell receptor, pCDTCR1 Human Human LDILDTAGL HLA-A2.1 Lentiviral   Add to Cart   Datasheet
    Unable to find the desired product? Explore the Filter Options at the top of the list.
    Key Updates
    Newsletter NEWSLETTER

    The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

    LEARN MORE NEWSLETTER
    New Solution NEW SOLUTION

    CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

    LEARN MORE SOLUTION
    NOVEL SOLUTION NOVEL TECHNOLOGY

    Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

    LEARN MORE NOVEL TECHNOLOGY
    NEW TECHNOLOGY NEW SOLUTION

    Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

    LEARN MORE SOLUTION
    Receive our latest news and insights.